APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bordetella Vaccine for Dogs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bordetella Vaccine for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025172 pages

Choose your research edition.

Industry ResearchBordetella Vaccine for Dogs Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Bordetella Vaccine for Dogs Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Bordetella Vaccine for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bordetella Vaccine for Dogs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Bordetella Vaccine for Dogs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bordetella Vaccine for Dogs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bordetella Vaccine for Dogs include Elanco, Boehringer Ingelheim(Merial), Merck Animal Health and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bordetella Vaccine for Dogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bordetella Vaccine for Dogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bordetella Vaccine for Dogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bordetella Vaccine for Dogs market size, projected growth trends, production technologies, key applications, and end-use industries.

Bordetella Vaccine for Dogs Segment by Company

Elanco

Boehringer Ingelheim(Merial)

Merck Animal Health

Zoetis

Bordetella Vaccine for Dogs Segment by Type

Injectable Bordetella Vaccine

Oral Bordetella Vaccine

Intranasal Bordetella Vaccine

Bordetella Vaccine for Dogs Segment by Application

Puppies

Adult Dogs

Bordetella Vaccine for Dogs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bordetella Vaccine for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bordetella Vaccine for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bordetella Vaccine for Dogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bordetella Vaccine for Dogs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bordetella Vaccine for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bordetella Vaccine for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bordetella Vaccine for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bordetella Vaccine for Dogs Industry Trends Table 2. Bordetella Vaccine for Dogs Industry Drivers Table 3. Bordetella Vaccine for Dogs Industry Opportunities and Challenges Table 4. Bordetella Vaccine for Dogs Industry Restraints Table 5. Global Bordetella Vaccine for Dogs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bordetella Vaccine for Dogs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bordetella Vaccine for Dogs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Bordetella Vaccine for Dogs Sales Market Share by Manufacturers Table 9. Global Bordetella Vaccine for Dogs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Bordetella Vaccine for Dogs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bordetella Vaccine for Dogs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bordetella Vaccine for Dogs Manufacturers, Product Type & Application Table 13. Global Bordetella Vaccine for Dogs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bordetella Vaccine for Dogs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injectable Bordetella Vaccine Table 17. Major Manufacturers of Oral Bordetella Vaccine Table 18. Major Manufacturers of Intranasal Bordetella Vaccine Table 19. Global Bordetella Vaccine for Dogs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Bordetella Vaccine for Dogs Sales by Type (2021-2026) & (k units) Table 21. Global Bordetella Vaccine for Dogs Sales by Type (2027-2032) & (k units) Table 22. Global Bordetella Vaccine for Dogs Sales Market Share by Type (2021-2026) Table 23. Global Bordetella Vaccine for Dogs Sales Market Share by Type (2027-2032) Table 24. Global Bordetella Vaccine for Dogs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Bordetella Vaccine for Dogs Revenue by Type (2021-2026) & (k units) Table 26. Global Bordetella Vaccine for Dogs Revenue by Type (2027-2032) & (k units) Table 27. Global Bordetella Vaccine for Dogs Revenue Market Share by Type (2021-2026) Table 28. Global Bordetella Vaccine for Dogs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Puppies Table 30. Major Manufacturers of Adult Dogs Table 31. Global Bordetella Vaccine for Dogs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Bordetella Vaccine for Dogs Sales by Application (2021-2026) & (k units) Table 33. Global Bordetella Vaccine for Dogs Sales by Application (2027-2032) & (k units) Table 34. Global Bordetella Vaccine for Dogs Sales Market Share by Application (2021-2026) Table 35. Global Bordetella Vaccine for Dogs Sales Market Share by Application (2027-2032) Table 36. Global Bordetella Vaccine for Dogs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Bordetella Vaccine for Dogs Revenue by Application (2021-2026) & (k units) Table 38. Global Bordetella Vaccine for Dogs Revenue by Application (2027-2032) & (k units) Table 39. Global Bordetella Vaccine for Dogs Revenue Market Share by Application (2021-2026) Table 40. Global Bordetella Vaccine for Dogs Revenue Market Share by Application (2027-2032) Table 41. Global Bordetella Vaccine for Dogs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Bordetella Vaccine for Dogs Sales by Region (2021-2026) & (k units) Table 43. Global Bordetella Vaccine for Dogs Sales Market Share by Region (2021-2026) Table 44. Global Bordetella Vaccine for Dogs Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Bordetella Vaccine for Dogs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Bordetella Vaccine for Dogs Sales by Country (2021-2026) & (k units) Table 48. North America Bordetella Vaccine for Dogs Sales by Country (2027-2032) & (k units) Table 49. Europe Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Bordetella Vaccine for Dogs Sales by Country (2021-2026) & (k units) Table 51. Europe Bordetella Vaccine for Dogs Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Bordetella Vaccine for Dogs Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Bordetella Vaccine for Dogs Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Bordetella Vaccine for Dogs Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Bordetella Vaccine for Dogs Sales by Country (2027-2032) & (k units) Table 58. Global Bordetella Vaccine for Dogs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Bordetella Vaccine for Dogs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Bordetella Vaccine for Dogs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Bordetella Vaccine for Dogs Revenue Market Share by Region (2021-2026) Table 62. Global Bordetella Vaccine for Dogs Revenue Market Share by Region (2027-2032) Table 63. Elanco Company Information Table 64. Elanco Business Overview Table 65. Elanco Bordetella Vaccine for Dogs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Elanco Bordetella Vaccine for Dogs Product Portfolio Table 67. Elanco Recent Development Table 68. Boehringer Ingelheim(Merial) Company Information Table 69. Boehringer Ingelheim(Merial) Business Overview Table 70. Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Product Portfolio Table 72. Boehringer Ingelheim(Merial) Recent Development Table 73. Merck Animal Health Company Information Table 74. Merck Animal Health Business Overview Table 75. Merck Animal Health Bordetella Vaccine for Dogs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Animal Health Bordetella Vaccine for Dogs Product Portfolio Table 77. Merck Animal Health Recent Development Table 78. Zoetis Company Information Table 79. Zoetis Business Overview Table 80. Zoetis Bordetella Vaccine for Dogs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Zoetis Bordetella Vaccine for Dogs Product Portfolio Table 82. Zoetis Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Bordetella Vaccine for Dogs Distributors List Table 86. Bordetella Vaccine for Dogs Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Bordetella Vaccine for Dogs Product Image Figure 2. Global Bordetella Vaccine for Dogs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bordetella Vaccine for Dogs Market Size (2021-2032) & (US$ Million) Figure 4. Global Bordetella Vaccine for Dogs Sales (2021-2032) & (k units) Figure 5. Global Bordetella Vaccine for Dogs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bordetella Vaccine for Dogs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injectable Bordetella Vaccine Image Figure 9. Oral Bordetella Vaccine Image Figure 10. Intranasal Bordetella Vaccine Image Figure 11. Global Bordetella Vaccine for Dogs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Bordetella Vaccine for Dogs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Bordetella Vaccine for Dogs Sales Market Share by Type (2021-2032) Figure 14. Global Bordetella Vaccine for Dogs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Bordetella Vaccine for Dogs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Bordetella Vaccine for Dogs Revenue Market Share by Type (2021-2032) Figure 17. Puppies Image Figure 18. Adult Dogs Image Figure 19. Global Bordetella Vaccine for Dogs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Bordetella Vaccine for Dogs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bordetella Vaccine for Dogs Sales Market Share by Application (2021-2032) Figure 22. Global Bordetella Vaccine for Dogs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Bordetella Vaccine for Dogs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Bordetella Vaccine for Dogs Revenue Market Share by Application (2021-2032) Figure 25. North America Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Bordetella Vaccine for Dogs Sales Market Share by Country (2021-2032) Figure 27. U.S. Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Bordetella Vaccine for Dogs Sales Market Share by Country (2021-2032) Figure 32. Germany Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Bordetella Vaccine for Dogs Sales Market Share by Country (2021-2032) Figure 39. China Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Bordetella Vaccine for Dogs Sales Market Share by Country (2021-2032) Figure 47. Brazil Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Bordetella Vaccine for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Bordetella Vaccine for Dogs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Bordetella Vaccine for Dogs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Bordetella Vaccine for Dogs Revenue (2021-2032) & (US$ Million) Figure 58. North America Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Bordetella Vaccine for Dogs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Bordetella Vaccine for Dogs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Bordetella Vaccine for Dogs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bordetella Vaccine for Dogs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Bordetella Vaccine for Dogs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Bordetella Vaccine
  • Oral Bordetella Vaccine
  • Intranasal Bordetella Vaccine
Applications
  • Puppies
  • Adult Dogs
Companies covered
  • Elanco
  • Boehringer Ingelheim(Merial)
  • Merck Animal Health
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bordetella Vaccine for Dogs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bordetella Vaccine for Dogs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bordetella Vaccine for Dogs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bordetella Vaccine for Dogs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bordetella Vaccine for Dogs Market Dynamics
  1. 2.1 Bordetella Vaccine for Dogs Industry Trends
  2. 2.2 Bordetella Vaccine for Dogs Industry Drivers
  3. 2.3 Bordetella Vaccine for Dogs Industry Opportunities and Challenges
  4. 2.4 Bordetella Vaccine for Dogs Industry Restraints
3 Bordetella Vaccine for Dogs Market by Manufacturers
  1. 3.1 Global Bordetella Vaccine for Dogs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bordetella Vaccine for Dogs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bordetella Vaccine for Dogs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bordetella Vaccine for Dogs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bordetella Vaccine for Dogs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bordetella Vaccine for Dogs Manufacturers, Product Type & Application
  7. 3.7 Global Bordetella Vaccine for Dogs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bordetella Vaccine for Dogs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bordetella Vaccine for Dogs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bordetella Vaccine for Dogs Tier 1, Tier 2, and Tier 3
4 Bordetella Vaccine for Dogs Market by Type
  1. 4.1 Bordetella Vaccine for Dogs Type Introduction
  2. 4.1.1 Injectable Bordetella Vaccine
  3. 4.1.2 Oral Bordetella Vaccine
  4. 4.1.3 Intranasal Bordetella Vaccine
  5. 4.2 Global Bordetella Vaccine for Dogs Sales by Type
  6. 4.2.1 Global Bordetella Vaccine for Dogs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bordetella Vaccine for Dogs Sales by Type (2021-2032)
  8. 4.2.3 Global Bordetella Vaccine for Dogs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Bordetella Vaccine for Dogs Revenue by Type
  10. 4.3.1 Global Bordetella Vaccine for Dogs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bordetella Vaccine for Dogs Revenue by Type (2021-2032)
  12. 4.3.3 Global Bordetella Vaccine for Dogs Revenue Market Share by Type (2021-2032)
5 Bordetella Vaccine for Dogs Market by Application
  1. 5.1 Bordetella Vaccine for Dogs Application Introduction
  2. 5.1.1 Puppies
  3. 5.1.2 Adult Dogs
  4. 5.2 Global Bordetella Vaccine for Dogs Sales by Application
  5. 5.2.1 Global Bordetella Vaccine for Dogs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bordetella Vaccine for Dogs Sales by Application (2021-2032)
  7. 5.2.3 Global Bordetella Vaccine for Dogs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Bordetella Vaccine for Dogs Revenue by Application
  9. 5.3.1 Global Bordetella Vaccine for Dogs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bordetella Vaccine for Dogs Revenue by Application (2021-2032)
  11. 5.3.3 Global Bordetella Vaccine for Dogs Revenue Market Share by Application (2021-2032)
6 Global Bordetella Vaccine for Dogs Sales by Region
  1. 6.1 Global Bordetella Vaccine for Dogs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bordetella Vaccine for Dogs Sales by Region (2021-2032)
  3. 6.2.1 Global Bordetella Vaccine for Dogs Sales by Region (2021-2026)
  4. 6.2.2 Global Bordetella Vaccine for Dogs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bordetella Vaccine for Dogs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bordetella Vaccine for Dogs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bordetella Vaccine for Dogs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bordetella Vaccine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bordetella Vaccine for Dogs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bordetella Vaccine for Dogs Revenue by Region
  1. 7.1 Global Bordetella Vaccine for Dogs Revenue by Region
  2. 7.1.1 Global Bordetella Vaccine for Dogs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bordetella Vaccine for Dogs Revenue by Region (2021-2026)
  4. 7.1.3 Global Bordetella Vaccine for Dogs Revenue by Region (2027-2032)
  5. 7.1.4 Global Bordetella Vaccine for Dogs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bordetella Vaccine for Dogs Revenue (2021-2032)
  8. 7.2.2 North America Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bordetella Vaccine for Dogs Revenue (2021-2032)
  11. 7.3.2 Europe Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bordetella Vaccine for Dogs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bordetella Vaccine for Dogs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bordetella Vaccine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Elanco
  2. 8.1.1 Elanco Company Information
  3. 8.1.2 Elanco Business Overview
  4. 8.1.3 Elanco Bordetella Vaccine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Elanco Bordetella Vaccine for Dogs Product Portfolio
  6. 8.1.5 Elanco Recent Developments
  7. 8.2 Boehringer Ingelheim(Merial)
  8. 8.2.1 Boehringer Ingelheim(Merial) Company Information
  9. 8.2.2 Boehringer Ingelheim(Merial) Business Overview
  10. 8.2.3 Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Product Portfolio
  12. 8.2.5 Boehringer Ingelheim(Merial) Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Bordetella Vaccine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Bordetella Vaccine for Dogs Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Zoetis
  20. 8.4.1 Zoetis Company Information
  21. 8.4.2 Zoetis Business Overview
  22. 8.4.3 Zoetis Bordetella Vaccine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zoetis Bordetella Vaccine for Dogs Product Portfolio
  24. 8.4.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bordetella Vaccine for Dogs Value Chain Analysis
  2. 9.1.1 Bordetella Vaccine for Dogs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bordetella Vaccine for Dogs Production Mode & Process
  6. 9.2 Bordetella Vaccine for Dogs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bordetella Vaccine for Dogs Distributors
  9. 9.2.3 Bordetella Vaccine for Dogs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst